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Abstract 
 
Proteus mirabilis has previously been shown to be capable of persisting in the rat kidney for 
up to 8 weeks and induces many physiological changes following a single inoculation of the 
urinary bladder. The present study examined kidney tissue from infected animals for evi-
dence of renal damage. The earliest histologic changes seen on the 2nd and 4th days, consisted 
of mild cellular sloughing and edema associated with mononuclear infiltration in the me-
dulla and to a lesser extent in the cortex. On the 1st and following weeks, tubular atrophy, 
interstitial fibrosis, and a mononuclear infiltrate had advanced in the renal parenchyma re-
sulting in chronic pyelonephritis. The observed renal degenerations with a corresponding 
ascending bacterial infection in the intra-renal reflux suggest that Proteus mirabilis is capa-
ble of producing chronic pyelonephritis in the rats after a single reflux challenge. 
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Introduction 
 
Urinary tract infection (UTI) is an inflammatory response 
of the urothelium to bacterial invasion that is usually as-
sociated with the bacteruria and pyuria [1].  Proteus mir-
abilis (P. mirabilis) is one of the most common Gram-
negative pathogens that infect the upper urinary tract. 
Proteus mirabilis causes UTIs with urinary tract abnor-
malities and is frequently isolated from the urine of eld-
erly patients [2], children and infants [3] and pregnant 
women [4].  This bacterium has a propensity for localiza-
tion in the kidney and in the bladder wash out. It is found 
in the kidney more often than E. coli and other bacteria 
owing to the production of urease and other virulence 
factors [5].  It can cause serious renal damage, such as 
acute pyelonephritis, bladder or renal stone, fever and 
bacterriemia [6].      
 
It is possible that bacterial infection may induce many 
morphological changes. Tubular atrophy and interstitial 
fibrosis were observed in rats infected with Ureaplasma 
urealyticum [7]. Increased inflammation was detected in 
both kidneys and urinary bladders in mice transurethrally 
treated with E coli [8]. Tissue damage, bacterial coloniza-
tion and inflammation were induced in the prostates of 
rats by P. mirabilis [9].     
 
Bacteriological investigation for renal infection has 
shown that proteus is the second major genus, however P. 
mirabilis is found to be the most common species in caus-
ing UTI in Iraqi population [10]. Experimental model has 
been developed for ascending non-obstructive urinary 
tract infection in rats to study the renal functions caused 
by a strain of P. mirabilis isolated from Iraqi patients with 
UTI [11]. Aim of the present study is to observe the his-
topathological features that may be caused by the P. mir-
abilis strains from Iraq.   
 
Materials and Methods 
 
One hundred experimental and fifty control young adult 
female virgin Wister rats (150-180 g) were housed in 
plastic cages, had free access to laboratory chow and wa-
ter. P. mirabilis recovered from the urine of an Iraqi pa-
tient with chronic UTI (attending Baghdad Medical City 
Hospital) was cultured in Brain-heart infusion broth for 
18 hours at 37°C prior to bladder inoculation.  
 
Each experimental rat was inoculated through the urethra 
into the bladder with 0.5 ml of broth containing approxi-
mately 3×108 (log 8.5) viable organisms using an I.V. 
cannula. Control rats were inoculated with same volume 
of sterile broth. Ten experimental and five control animals 
were sacrificed at 2 and 4 days and at 1, 2, 3, 4, 5, 6, 7, 8 
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weeks after inoculation. The kidneys were removed and 
each kidney was bisected longitudinally into two halves; 
one half used for bacteriological study and the other half 
processed for morphological study. The halves used for 
bacteriological study were homogenized in 5 ml of sterile 
distilled water and serial dilutions (ten-folds) were pre-
pared in phosphate buffered saline (PH 7.4), 0.01ml of 
each dilution was inoculated onto MacConkey agar “Oxo-
id 115” and incubated for 24-48 hours at 37°C. The viable 
counts of bacteria were expressed as the logarithm of col-
ony forming units “Log CFU” per gram of kidney weight.  
The morphological halves were fixed in 10% formal sa-
line for 48 hours, and processed for light and electron 
microscopy. All data were analyzed by using Student t-
test. A  p value of < 0.05 was considered to be statistically 
significant.  
 
Results       
 
Infectivity 
The number of bacteria recovered from rats kidneys in-
fected with P. mirabilis is given in figure 1. Ascending 
infection was confirmed in 100% of the rats as deter-
mined by recovery of the bacteria from the kidneys 2-4 
days and 1-8 weeks after bladder infection. The bacterial 
infection varied throughout the experiment; there was a 
significant reduction (P < 0.01) in bacterial number re-
covered from the kidneys on the 2nd day, the count was 
log 5.4 ± 0.78 compared to bladder inoculation (log 8.5). 
On the 4th day, the recovered bacterial count increased 
sharply (Log 10. 3 ± 0.15) [P < 0.05] and remained about  
this level for about 7 days (P < 0.05). Over the 2nd week 
there was a rapid decline in bacterial number (Log 5.93 ± 
2.21) [P < 0.05] which remained approximately at the 
same level until the end of the experiment.  Mortality was 
not observed in the experimental rats during the period of 
this study and no bacterial infection was demonstrated in 
the controls.  
 
Histological observations 
On the day 2 and day 4 of the experiment, there was a 
mild change in the kidneys of the treated rats including 
hyperemia and edema of the medullary areas associated 
with infiltration of the inflammatory cells. In the mean 
time, the renal tubules showed signs of cloudy swelling 
with hydropic degeneration. There was dilatation of the 
proximal convoluted tubules and some of them lost their 
epithelial lining and filled with a heterogeneous eosino-
philic material and cell debris. These changes were asso-
ciated with high infiltration of mononuclear cells (Fig. 2 
A).       
 
The histologic changes in the kidneys progressed over the 
7-day and increased throughout the period of the experi-
ment. During the 1st week, cellular degeneration, with 
inflammatory cell infiltration of the cortex and medulla 
were obvious. Unorganized dilation of glomeruli and re-
nal tubular necrosis due to accumulation of fibrotic mate-
rial were observed (Fig. 2 B). At the 2nd and 3rd weeks, 
cell necrosis and coalescent suppurative were observed all 
over the kidneys. Chronic interstitial nephritis, which 
leads to some infarction foci, was developed (Fig. 2 C).           
 
 
 
Figure 1. Number of bacteria recovered from rat kidneys from day 1 to 8 weeks after bladder inoculation with   P. 
mirabilis. 
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Figure 2... Sample photographs from kidneys of the treated rats, showing dilated tubules and the presence of heteroge-
neous material within their lumens (A “after 4 days”), necrotic tubules (B “after 1 week”), dilated tubules and intersti-
tial fibrosis (C “after 3 weeks”), squamous metaplasia in the renal pelvis and renal papillary necrosis together with 
dilation of the renal tubules (D “after 5 weeks”), cystic dilatation of the renal tubules with variation in the diameter of 
the tubules and necrotic glomeruli (E “after 6 weeks”), interstitial fibrosis, necrotic glomeruli and remnants of removed 
stones (F “after 8 weeks”). All stages were associated with hyper-infiltration of mononuclear cells. H&E stain. 
 
During the 4th to 6th weeks of the experiment, chronic pye-
litis (Fig. 2 D) was encountered, with paplitis and squam-
ous metaplasia which led to the atrophy of the convoluted 
and collecting tubules or cystic dilatation with distraction 
of glomeruli which consequently led to irregular dilata-
tion in Bowman capsule (Fig. 2 E).  The sever changes 
observed in the 4th, 5th and 6th weeks were maintained in 
the 7th and 8th weeks.  In addition, more distraction ap-
pears in the kidney samples, due to high amount of lym-
phatic tissue precipitation. Thick lymphatic aggregation 
on the boundaries of the renal pelvis was also clear. The 
glomerular capsule was fibrotic and thickened. Kidney 
stones and infiltration of inflammatory cells were obvious 
(Fig. 2 F).   
No significant histological changes were seen in the con-
trol rats.  
 
Discussion 
 
P. mirabilis, a major cause of complicated urinary tract 
infection (UTI) in humans, primarily infects patients with 
long-term indwelling urinary catheters (>30 days) or indi-
viduals with anatomical abnormalities of the urinary tract 
[12].  Individuals suffering from urinary tract infections 
caused by P. mirabilis often develop bacteruria, cystitis, 
acute pyelonephritis, and kidney and bladder stones [13-
14]. Renal failure, urinary calculi, bladder dysfunction 
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and pyelonephritis were documented in rats inoculated 
with P. mirabilis [15]. 
 
Several procedures have been developed to study the pa-
thophysiology of kidney damage and other aspects on the 
host-parasite relationship in the UTI using E. coli [16, 
17], Ureaplasma urealyticum [7], P. mirabilis [9], and 
Pseudomonas aeruginosa [18]. To ensure a high fre-
quency of pyelonephritic infection, most experimental 
models applied mechanical manipulations, such as blad-
der or kidney massage [19, 20], abdominal operation with 
temporary ureteral ligation or puncture of the kidney or 
bladder wall [21]. The present ascending UTI infection 
with P. mirabilis is employed without mechanical ma-
nipulation and with little trauma or injury to the urinary 
tract.  
 
Mortality was reported in 16% of BALB/c mice intrave-
sicularly administered with 2 × 108 CFU of P. mirabilis 
[22] and in 35% of CBA/J mice using transurethral ad-
ministration of 109 CFU of P. mirabilis [5]. All of mice 
showed extensive and severe necrotizing pyelonephritis.  
However, renal calculi were not observed in the BALB/c 
mice but they were identified in the CBA/J mice. Mortal-
ity was also observed in 43.3% of dogs infected with E. 
coli; most of them showed chronic interstitial nephritis 
[23]. In the present study, no death was evident although 
proliferation of viable bacterial count was found to be 
associated with histologic changes in the kidney.  The 
presence or absence of mortality has been attributed to the 
bacterial strain isolate from the human [5] or might be 
due to species difference in the susceptibility to infection. 
 
We have reported [11] that P. mirabilis is capable of in-
ducing chronic renal infection in the rat after a single re-
flux challenge. The Infection was accompanied by vary-
ing degrees of renal failure, increased blood urea nitrogen 
and serum creatinine and reduced level of creatinine 
clearance. Present study has been undertaken to describe 
the pathological changes that might occur in the kidneys 
of rats inoculated with P. mirabilis isolated from the urine 
of an Iraqi patient suffering from chronic UTI.  
Two days after the inoculation of 0.5 ml of broth contain-
ing approximately 3×108 viable organisms, there was an 
incidence of pyelonephritis characterized by hyperemia 
and edema of the medullary areas associated with infiltra-
tion of the inflammatory cells. The pathological changes 
continued throughout the rest period of the experiment 
and developed into chronic pyelonephritis. The changes 
included interstitial inflammation, involving both cortex 
and medulla. The inflammatory changes were associated 
by infiltration mononuclear cell in the interstitium. The 
highest bacterial count in the present study was observed 
on the 4th day, this is consistent with the observation that 
a highest number of E. coli was recovered on the 3rd day 
of I.V. inoculation [20] and P. mirabilis on the 5th day of 
ascending inoculation [24]. This elevation in bacterial 
number might be the result of spread and extension of 
bacterial invasion towards the renal medulla and cortex.  
 
The observed inflammation was more severe in the me-
dulla than in the cortex, as infection continued, however, 
an increasing proportion of kidneys displayed cortical 
damage.  The cortical region showed severe interstitial 
fibrosis and was found to be infiltrated with large number 
of mononuclear cells with marked tubular and glomerular 
destruction. The cortical inflammation suggesting that 
infection had spread from the medulla. Identical findings 
were evident in rats infected with Ureaplasma urealyti-
cum [7]. The present study has also demonstrated the per-
sistence of P. mirabilis in the rat kidneys during the entire 
period of experiment with a corresponding histologic evi-
dence of chronic pyelonephritis. Bacterial invasion to the 
renal pelvis epithelium, the initial step in the renal infec-
tion is related to the poor blood circulation, higher con-
centration of urea, higher osmolality and lower PH  all of 
which tend to impair phagocytosis and inhibit comple-
ment effect [25]. The bacterial count fell down signifi-
cantly on the 2nd week. Niekel et al [26] and Brook et al 
[27] also found that the reduction in bacterial number (p. 
mirabilis and E.coli) was associated with domination of 
inflammatory cells in kidney tissues. The ability of P. 
mirabilis to colonize at the surface of the urinary tract is 
believed to be aided by characteristic known as swarming 
differentiation and migration [28]. Several potential viru-
lence factors may be responsible for the pathogenicity of 
P. mirabilis such as flagella, urease, and hemolysin [14].  
Fimbriae type I and P-fimbria have been reported to play 
a significant role in the infection induced by the E. coli 
[29-30]. E. coli bearing Dr fimbriae, was constructed and 
used to characterize persistence of infection and intersti-
tial tropism in an experimental model of ascending pye-
lonephritis [16]. The swarming ability and other virulence 
factors of the P. mirabilis strains isolated from Iraqi pat-
ents with UTI to colonize the surface of urinary tract and 
induce chronic pyelonephritis need further investigation. 
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